Histone deacetylase 3 suppresses Erk phosphorylation and matrix metalloproteinase (Mmp)-13 activity in chondrocytes.
Histone deacetylase (Hdac3) inhibitors are emerging therapies for many diseases including cancers and neurological disorders; however, these drugs are teratogens to the developing skeleton. Hdac3 is essential for proper endochondral ossification as its deletion in chondrocytes increases cytokine signaling and the expression of matrix remodeling enzymes. Here we explored the mechanism by which Hdac3 controls matrix metalloproteinase (Mmp)-13 expression in chondrocytes. In Hdac3-depleted chondrocytes, extracellular signal-regulated kinase (Erk)1/2 as well as its downstream substrate, Runx2, were hyperphosphorylated as a result of decreased expression and activity of the Erk1/2 specific phosphatase, Dusp6. Erk1/2 kinase inhibitors and Dusp6 adenoviruses reduced Mmp13 expression and partially rescued matrix production in Hdac3-deficient chondrocytes. Postnatal chondrocyte-specific deletion of Hdac3 with an inducible Col2a1-Cre caused premature production of pErk1/2 and Mmp13 in the growth plate. Thus, Hdac3 controls the temporal and spatial expression of tissue-remodeling genes in chondrocytes to ensure proper endochondral ossification during development.
a Mayo Graduate School , Rochester , MN , USA.|b Department of Biochemistry and Molecular Biology , Mayo Clinic , Rochester , MN , USA.
Lomeli R
LR
Carpio
c Department of Orthopedic Surgery , Mayo Clinic , Rochester , MN , USA.
Elizabeth W
EW
Bradley
b Department of Biochemistry and Molecular Biology , Mayo Clinic , Rochester , MN , USA.|c Department of Orthopedic Surgery , Mayo Clinic , Rochester , MN , USA.
Jennifer J
JJ
Westendorf
D000818:Animals; D002478:Cells, Cultured; D019902:Chondrocytes / Q000166:cytology / Q000378:metabolism*; D054642:Dual Specificity Phosphatase 6 / Q000235:genetics / Q000378:metabolism; D006132:Growth Plate / Q000166:cytology / Q000378:metabolism; D006655:Histone Deacetylases / Q000235:genetics / Q000378:metabolism*; D053509:Matrix Metalloproteinase 13 / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D048052:Mitogen-Activated Protein Kinase 3 / Q000235:genetics / Q000378:metabolism*; D010012:Osteogenesis / Q000502:physiology; D010766:Phosphorylation / Q000502:physiology; D000099186:Histone Deacetylase 3
D054642:Dual Specificity Phosphatase 6; D006655:Histone Deacetylases; D053509:Matrix Metalloproteinase 13; D048052:Mitogen-Activated Protein Kinase 3; D000099186:Histone Deacetylase 3; C517036:Dusp6 protein, mouse; C507081:Mmp13 protein, mouse
Cartilage; Dusp6; Erk1/2; Hdac3; MAPK; Runx2
Chem Res Toxicol. 2006 Feb;19(2):272-8
16485903
J Biol Chem. 2004 Oct 1;279(40):41998-2007
15292260
J Biol Chem. 2009 Nov 20;284(47):32533-43
19801668
Nature. 2000 Nov 16;408(6810):377-81
11099047
Science. 2005 Jan 14;307(5707):269-73
15653507
Genes Dev. 2004 Feb 1;18(3):290-305
14871928
Annu Rev Biochem. 2007;76:75-100
17362198
J Biol Chem. 1995 Jul 14;270(28):16483-6
7622446
J Bone Miner Res. 2006 Sep;21(9):1331-8
16939391
Bone. 2011 May 1;48(5):1117-26
21255693
Dev Cell. 2007 Jun;12(6):931-41
17543865
J Cancer Res Ther. 2014 Jul-Sep;10(3):469-78
25313724
Mol Med. 2011 May-Jun;17(5-6):333-52
21556484
J Biol Chem. 2004 Feb 6;279(6):4588-95
14617631
Birth Defects Res C Embryo Today. 2008 Jun;84(2):131-54
18546337
Physiol Rev. 2015 Oct;95(4):1359-81
26378079
J Cell Biol. 2010 Dec 27;191(7):1271-83
21173110
J Biol Chem. 2000 Jul 7;275(27):20436-43
10777477
Sci Signal. 2016 Aug 09;9(440):ra79
27507649
Nature. 1997 Sep 25;389(6649):349-52
9311776
J Biol Chem. 2000 Feb 11;275(6):4453-9
10660618
PLoS One. 2010 Jul 09;5(7):e11492
20628553
Arthritis Res. 2002;4(3):157-64
12010565
Bone. 2013 Jan;52(1):296-307
23085085
J Biol Chem. 2006 Jun 16;281(24):16502-11
16613856
J Orthop Res. 2011 Mar;29(3):375-9
20922792
Bioessays. 2000 Feb;22(2):138-47
10655033
Ann N Y Acad Sci. 2007 Nov;1116:196-207
18083928
Toxicol Sci. 2007 Aug;98(2):582-8
17517827
FEBS Lett. 2009 Apr 2;583(7):1141-6
19264160
Toxicol Sci. 2015 Nov;148(1):220-8
26251326
Am J Physiol Cell Physiol. 2010 Aug;299(2):C189-202
20463170
Development. 2007 Jan;134(1):167-76
17164422
Nat Rev Genet. 2009 Jan;10(1):32-42
19065135
Gene. 2005 Dec 19;363:15-23
16289629
Neurology. 2001 Aug 14;57(3):445-9
11502911
Birth Defects Res B Dev Reprod Toxicol. 2005 Oct;74(5):392-8
16193500
Dev Dyn. 2006 Sep;235(9):2603-12
16894608
Science. 2009 Aug 14;325(5942):834-40
19608861
PLoS Genet. 2014 Dec 04;10(12):e1004820
25474590
J Bone Miner Res. 2012 Mar;27(3):538-51
22072425
Dev Cell. 2005 May;8(5):739-50
15866164
Mol Cell. 2008 Apr 11;30(1):61-72
18406327
Toxicol Appl Pharmacol. 2007 Apr 15;220(2):178-85
17320131
Exp Cell Res. 2006 Apr 15;312(7):1079-92
16457813
Epilepsia. 2004 Nov;45(11):1330-7
15509233
Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12097-102
25092332
Nat Protoc. 2008;3(8):1253-60
18714293
J Biol Chem. 2013 Apr 5;288(14):9572-82
23408427
Epilepsia. 2001 Sep;42(9):1141-7
11580761
Nature. 2003 May 15;423(6937):332-6
12748651
J Biol Chem. 2009 Dec 11;284(50):34901-10
19822520
Oncogene. 1999 Dec 23;18(56):7948-57
10637505
Mol Cell Biol. 2008 Jan;28(1):344-57
17967876
Mol Cancer Ther. 2010 Dec;9(12 ):3210-20
21159607
Mol Cell Biol. 2009 Nov;29(21):5843-57
19737917